Standard BioTools has a very small Wall Street following as can be seen above. On average, they expect the company to lose $0 ...
Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...
In a bold strategic divergence from its tech peers, International Business Machines Corp. (NYSE: IBM) announced on Monday its plan to acquire data-streaming specialist Confluent for approximately $11 ...
As power demand surges in the AI era, the protonic ceramic electrochemical cell (PCEC), which can simultaneously produce electricity and hydrogen, is gaining attention as a next-generation energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback